These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19775727)

  • 1. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
    Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
    Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
    Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
    Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
    Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
    Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
    Broehm CJ; Wu J; Gullapalli RR; Bocklage T
    Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
    Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
    Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
    Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
    J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone.
    Demicco EG; Wang WL; Madewell JE; Huang D; Bui MM; Bridge JA; Meis JM
    Am J Surg Pathol; 2013 May; 37(5):752-62. PubMed ID: 23588370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel sarcoma with dual differentiation: clinicopathologic and molecular characterization of a combined synovial sarcoma and extraskeletal myxoid chondrosarcoma.
    Vergara-Lluri ME; Stohr BA; Puligandla B; Brenholz P; Horvai AE
    Am J Surg Pathol; 2012 Jul; 36(7):1093-8. PubMed ID: 22743288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
    Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
    J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.
    Yamaguchi U; Hasegawa T; Morimoto Y; Tateishi U; Endo M; Nakatani F; Kawai A; Chuman H; Beppu Y; Endo M; Kurotaki H; Furuta K
    J Clin Pathol; 2005 Oct; 58(10):1051-6. PubMed ID: 16189150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
    Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
    Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
    Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
    J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.
    Filion C; Motoi T; Olshen AB; Laé M; Emnett RJ; Gutmann DH; Perry A; Ladanyi M; Labelle Y
    J Pathol; 2009 Jan; 217(1):83-93. PubMed ID: 18855877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
    Urbini M; Astolfi A; Pantaleo MA; Serravalle S; Dei Tos AP; Picci P; Indio V; Sbaraglia M; Benini S; Righi A; Gambarotti M; Gronchi A; Colombo C; Dagrada GP; Pilotti S; Maestro R; Polano M; Saponara M; Tarantino G; Pession A; Biasco G; Casali PG; Stacchiotti S
    Genes Chromosomes Cancer; 2017 Jul; 56(7):582-586. PubMed ID: 28383167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
    Stacchiotti S; Pantaleo MA; Astolfi A; Dagrada GP; Negri T; Dei Tos AP; Indio V; Morosi C; Gronchi A; Colombo C; Conca E; Toffolatti L; Tazzari M; Crippa F; Maestro R; Pilotti S; Casali PG
    Eur J Cancer; 2014 Jun; 50(9):1657-64. PubMed ID: 24703573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases.
    Jakowski JD; Wakely PE
    Cancer; 2007 Oct; 111(5):298-305. PubMed ID: 17676582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraskeletal myxoid chondrosarcoma: combining cytopathology with molecular testing to achieve diagnostic accuracy.
    Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):293-299. PubMed ID: 32828707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
    Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
    Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
    Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
    Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.